Cargando…

Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model

BACKGROUND: Twitcher mouse (twi/twi) is an authentic murine model of Krabbe's disease. Accumulation of psychosine, resulting in apoptosis of oligodendrocytes and subsequent demyelination, is a cardinal event to the pathogenesis of this disease. Moreover, recruitment of inflammatory cells plays...

Descripción completa

Detalles Bibliográficos
Autores principales: Kagitani-Shimono, Kuriko, Mohri, Ikuko, Fujitani, Yasushi, Suzuki, Kinuko, Ozono, Keiichi, Urade, Yoshihiro, Taniike, Masako
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1112612/
https://www.ncbi.nlm.nih.gov/pubmed/15813970
http://dx.doi.org/10.1186/1742-2094-2-10
_version_ 1782123943582236672
author Kagitani-Shimono, Kuriko
Mohri, Ikuko
Fujitani, Yasushi
Suzuki, Kinuko
Ozono, Keiichi
Urade, Yoshihiro
Taniike, Masako
author_facet Kagitani-Shimono, Kuriko
Mohri, Ikuko
Fujitani, Yasushi
Suzuki, Kinuko
Ozono, Keiichi
Urade, Yoshihiro
Taniike, Masako
author_sort Kagitani-Shimono, Kuriko
collection PubMed
description BACKGROUND: Twitcher mouse (twi/twi) is an authentic murine model of Krabbe's disease. Accumulation of psychosine, resulting in apoptosis of oligodendrocytes and subsequent demyelination, is a cardinal event to the pathogenesis of this disease. Moreover, recruitment of inflammatory cells plays a significant role in the pathological process in the twi/twi central and peripheral nervous systems. In this study, we investigated the 1) the relationship between tumor necrosis factor-α (TNFα), pro-inflammatory cytokine, and the progression of this disease and 2) effect of the anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor. METHODS: We quantified the expression level of TNFα and TNF-receptor mRNA in twi/twi using semi-quantitative RT-PCR. The relationship between TNFα expression, apoptosis of oligodendrocytes and demyelination was studied with immunohistochemistry and TUNEL method. We then treated twi/twi with a daily intraperitoneal injection of ibudilast (10 mg/kg), which suppress TNFα production in the brain. RESULTS: We found that TNFα-immunoreactive microglia/macrophages appeared in the twi/twi brain and that the mRNA levels of TNFα and TNF-receptor 1 was increased with the progression of demyelination. The distribution profile of TNFα-immunoreactive microglia/macrophages overlapped that of TUNEL-positive oligodendrocytes in the twi/twi brain. When twi/twi was treated with ibudilast from PND30, the number of oligodendrocytes undergoing apoptosis was markedly reduced and demyelination was milder. Obvious improvement of clinical symptom was noted in two of five. The failure of constant clinical improvement by ibudilast may result from hepatotoxicity and/or the inhibition of proliferation of NG2-positive oligodendrocyte precursors. CONCLUSION: We conclude that anti-inflammatory therapy by a phosphodiesterase inhibitor can be considered as a novel alternative therapy for Krabbe's disease.
format Text
id pubmed-1112612
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-11126122005-05-14 Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model Kagitani-Shimono, Kuriko Mohri, Ikuko Fujitani, Yasushi Suzuki, Kinuko Ozono, Keiichi Urade, Yoshihiro Taniike, Masako J Neuroinflammation Research BACKGROUND: Twitcher mouse (twi/twi) is an authentic murine model of Krabbe's disease. Accumulation of psychosine, resulting in apoptosis of oligodendrocytes and subsequent demyelination, is a cardinal event to the pathogenesis of this disease. Moreover, recruitment of inflammatory cells plays a significant role in the pathological process in the twi/twi central and peripheral nervous systems. In this study, we investigated the 1) the relationship between tumor necrosis factor-α (TNFα), pro-inflammatory cytokine, and the progression of this disease and 2) effect of the anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor. METHODS: We quantified the expression level of TNFα and TNF-receptor mRNA in twi/twi using semi-quantitative RT-PCR. The relationship between TNFα expression, apoptosis of oligodendrocytes and demyelination was studied with immunohistochemistry and TUNEL method. We then treated twi/twi with a daily intraperitoneal injection of ibudilast (10 mg/kg), which suppress TNFα production in the brain. RESULTS: We found that TNFα-immunoreactive microglia/macrophages appeared in the twi/twi brain and that the mRNA levels of TNFα and TNF-receptor 1 was increased with the progression of demyelination. The distribution profile of TNFα-immunoreactive microglia/macrophages overlapped that of TUNEL-positive oligodendrocytes in the twi/twi brain. When twi/twi was treated with ibudilast from PND30, the number of oligodendrocytes undergoing apoptosis was markedly reduced and demyelination was milder. Obvious improvement of clinical symptom was noted in two of five. The failure of constant clinical improvement by ibudilast may result from hepatotoxicity and/or the inhibition of proliferation of NG2-positive oligodendrocyte precursors. CONCLUSION: We conclude that anti-inflammatory therapy by a phosphodiesterase inhibitor can be considered as a novel alternative therapy for Krabbe's disease. BioMed Central 2005-04-06 /pmc/articles/PMC1112612/ /pubmed/15813970 http://dx.doi.org/10.1186/1742-2094-2-10 Text en Copyright © 2005 Kagitani-Shimono et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Kagitani-Shimono, Kuriko
Mohri, Ikuko
Fujitani, Yasushi
Suzuki, Kinuko
Ozono, Keiichi
Urade, Yoshihiro
Taniike, Masako
Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model
title Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model
title_full Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model
title_fullStr Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model
title_full_unstemmed Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model
title_short Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model
title_sort anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1112612/
https://www.ncbi.nlm.nih.gov/pubmed/15813970
http://dx.doi.org/10.1186/1742-2094-2-10
work_keys_str_mv AT kagitanishimonokuriko antiinflammatorytherapybyibudilastaphosphodiesteraseinhibitorindemyelinationoftwitcherageneticdemyelinationmodel
AT mohriikuko antiinflammatorytherapybyibudilastaphosphodiesteraseinhibitorindemyelinationoftwitcherageneticdemyelinationmodel
AT fujitaniyasushi antiinflammatorytherapybyibudilastaphosphodiesteraseinhibitorindemyelinationoftwitcherageneticdemyelinationmodel
AT suzukikinuko antiinflammatorytherapybyibudilastaphosphodiesteraseinhibitorindemyelinationoftwitcherageneticdemyelinationmodel
AT ozonokeiichi antiinflammatorytherapybyibudilastaphosphodiesteraseinhibitorindemyelinationoftwitcherageneticdemyelinationmodel
AT uradeyoshihiro antiinflammatorytherapybyibudilastaphosphodiesteraseinhibitorindemyelinationoftwitcherageneticdemyelinationmodel
AT taniikemasako antiinflammatorytherapybyibudilastaphosphodiesteraseinhibitorindemyelinationoftwitcherageneticdemyelinationmodel